Renaissance Technologies - XENON PHARMACEUTICALS INC ownership

XENON PHARMACEUTICALS INC's ticker is XENE and the CUSIP is 98420N105. A total of 93 filers reported holding XENON PHARMACEUTICALS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
Renaissance Technologies ownership history of XENON PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$748
-100.0%
21,900
-85.5%
0.00%
-80.0%
Q1 2022$4,609,000
-61.3%
150,777
-60.4%
0.01%
-66.7%
Q4 2021$11,899,000
+25.8%
380,877
-38.5%
0.02%
+25.0%
Q3 2021$9,459,000
-22.8%
619,077
-5.9%
0.01%
-20.0%
Q2 2021$12,252,000
-1.2%
657,977
-5.1%
0.02%0.0%
Q1 2021$12,404,000
+4.7%
692,977
-10.0%
0.02%
+15.4%
Q4 2020$11,842,000
+18.4%
769,977
-14.8%
0.01%
+30.0%
Q3 2020$9,999,000
-23.0%
903,277
-12.8%
0.01%
-9.1%
Q2 2020$12,982,000
+45.3%
1,035,277
+31.4%
0.01%
+22.2%
Q1 2020$8,937,000
+14.4%
788,077
+32.3%
0.01%
+50.0%
Q4 2019$7,809,000
+77.4%
595,677
+21.9%
0.01%
+50.0%
Q3 2019$4,402,000
-6.1%
488,600
+2.8%
0.00%0.0%
Q2 2019$4,688,000
-2.3%
475,500
+0.7%
0.00%0.0%
Q1 2019$4,799,000
+34.4%
472,300
-16.5%
0.00%0.0%
Q4 2018$3,570,000
-48.7%
565,700
+7.3%
0.00%
-42.9%
Q3 2018$6,961,000
+17.7%
527,337
-32.2%
0.01%
+133.3%
Q2 2018$5,914,000
+319.1%
777,500
+170.0%
0.00%
+50.0%
Q1 2018$1,411,000
+100.7%
288,000
+15.7%
0.00%
+100.0%
Q4 2017$703,000
+52.5%
249,000
+59.2%
0.00%0.0%
Q3 2017$461,000
+12.4%
156,400
+20.0%
0.00%0.0%
Q2 2017$410,000
-52.8%
130,300
-40.0%
0.00%0.0%
Q1 2017$868,000
-1.3%
217,090
+90.1%
0.00%0.0%
Q4 2016$879,000
+12.8%
114,200
+18.7%
0.00%0.0%
Q3 2016$779,000
+172.4%
96,200
+98.4%
0.00%0.0%
Q2 2016$286,000
+21.2%
48,500
+43.5%
0.00%
Q1 2016$236,000
-24.8%
33,800
-13.6%
0.00%
-100.0%
Q4 2015$314,000
+85.8%
39,105
+90.8%
0.00%
Q3 2015$169,000
-65.1%
20,500
-51.2%
0.00%
-100.0%
Q2 2015$484,00042,0000.00%
Other shareholders
XENON PHARMACEUTICALS INC shareholders Q1 2021
NameSharesValueWeighting ↓
Ally Bridge Group (NY) LLC 266,961$9,119,38810.70%
COMMODORE CAPITAL LP 1,845,000$63,025,2007.37%
TLS Advisors LLC 32,956$1,1264.56%
Altium Capital Management LP 228,000$7,788,4804.06%
Paradigm Biocapital Advisors LP 1,491,835$50,961,0843.46%
GREAT POINT PARTNERS LLC 500,001$17,080,0343.11%
DAFNA Capital Management LLC 280,538$9,583,1782.98%
Nan Fung Group Holdings Ltd 106,680$3,644,1892.95%
Affinity Asset Advisors, LLC 300,438$10,262,9622.89%
Avoro Capital Advisors LLC 4,900,000$167,384,0002.61%
View complete list of XENON PHARMACEUTICALS INC shareholders